Last reviewed · How we verify

NCT07200635

Test Serum Clinical Study

Completed NA Last updated 17 November 2025
What this trial tests

NA trial testing HA injection in Redness in 90 participants. Completed in 9 September 2025.

Timeline
23 June 2025
Primary endpoint
9 September 2025
9 September 2025

Quick facts

Lead sponsorChinaNorm
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment90
Start date23 June 2025
Primary completion9 September 2025
Estimated completion9 September 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

ChinaNorm

Who can join

Adults 25 to 40, female only, with Redness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This 4-week, mono-centric clinical study employed a randomized three-arm design to evaluate the efficacy of a test serum. The study compared three interventions: the test serum used alone, the test serum used in combination with hyaluronic acid (HA) injection, and HA injection alone. It aimed to assess their effects on skin quality and wrinkles in 90 healthy Chinese female subjects aged 25-40. Evaluations were conducted at multiple timepoints through clinical assessments, instrumental measurements, and image analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other ChinaNorm trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07200635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing